Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
December 16, 2014
Anthony Basile et al v. Valeant Pharmaceutical International, Inc. et al
Case Number:
8:14-cv-02004
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- AFN Law PLLC
- Akin Gump
- Bernstein Litowitz
- Bottini & Bottini
- Cotchett Pitre
- Debevoise & Plimpton
- Dechert LLP
- Fried Frank
- Hueston Hennigan
- Kessler Topaz
- Kirkland & Ellis
- Kramer Levin
- Labaton Keller
- Larson LLP
- Latham & Watkins
- Loeb & Loeb
- McGuireWoods
- Murray Murphy
- Rosen Law Firm PA
- Sullivan & Cromwell
- Susman Godfrey
- Theodora Oringher
Companies
- Allergan PLC
- Bank of America Corp.
- Barclays PLC
- Pershing Square Capital Management LP
- RBC Capital Markets
- State Teachers Retirement System of Ohio
- Two Sigma Investments LP
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 29, 2018
Investors Seek Early OK For $290M Valeant, Pershing Deals
Investors who sued Pershing Square Capital Management LP and Valeant Pharmaceuticals over their alleged insider trading scheme ahead of Valeant's failed $55 billion effort to acquire Allergan Inc. filed papers Friday to begin the approval process for $290 million in settlements.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login